Putting enzymes on pause
plant's death, which in turn decreases crop yield and contributes to the global food insecurity problem. I know that when Gene X is absent, the fungi are non-infectious, and the plant survives. A key point to note is that these differences provide sufficient target specificity to develop fungal-specific inhibitors rather than human-specific ones. Through this, Cdc14 inhibitors make excellent candidates for safe and specific treatments. This leads us to conclude that the protein within Gene X that most likely causes infection is Cdc14. Through this research project, my team aims to inhibit the fungal pathogen by targeting Cdc14 . Cdc14 belongs to a large group of dual-specific phosphatases that play pivotal roles in cell cycle regulation (Neitzel et al., 2018). First identified in S. cerevisiae , Cdc14 activity is required to counter the activity of cyclin-dependent kinases at the end of mitosis, allowing scrutiny of the anaphase-promoting complex, mitotic exit, and cytokinesis. More recent studies have found that Cdc14 phosphatases mediate DNA replication, damage response and repair, further highlighting their broad biological importance. Given that there are widespread evolutionary differences in the biology of this family in higher organisms, including possible non-mitotic functions and expanded subcellular localizations, the finding that Cdc14 functions have diverged from a simple tool for cell cycle regulation in early (prokaryotic-like) eukaryotes to a multimodal effector of cellular regulation in yeast and beyond is perhaps not that surprising. Structurally, Cdc14 phosphatases have conserved domains arranged in the following structure: the non- catalytic N-terminal and the catalytic C-terminal domains constitute the unique substrate specificity of Cdc14. At the same time, their active site establishes the conserved HCX 5 R motif, which contains a critical catalytic cysteine essential for dual specificity phosphatase activity in the dephosphorylation of phosphoserine and phosphothreonine residues (DeMarco et al., 2020). The conserved structure in various species, including pathogenic fungi, provides a basis for Cdc14 in different fungal species to become a target for broad-spectrum antifungal agents. These inhibitors, designed against Cdc14 active sites, could display inhibitory activity against diverse fungal species. I believe that Cdc14 is the target protein because it is conserved across species, plays a vital role in cell cycle regulation, and is less likely to induce resistance. Cdc14 is an evolutionarily conserved enzyme essential for general cell biology and, consequently, is found widely in simple and complex eukaryotes. While the overall features of eukaryotic protein kinases and phosphatases are highly conserved, and many are responsible for intercellular communication, subtle sequence differences exist across species. A key point to note is that these differences provide sufficient target specificity to develop fungal-specific inhibitors rather than human-specific ones. Through this, Cdc14 inhibitors make excellent candidates for safe and specific treatment. Cdc14 is crucial for regulating the fungal cell cycle and arresting it, particularly during the transition from mitosis to cytokinesis. Inhibiting this protein could prevent fungal reproduction and spread, reducing the incidence of plant diseases. Unlike other antifungal targets, targeting Cdc14 for therapeutic use is expected to slow the development of resistance more effectively. This is because multisite inhibitors that target Cdc14 might engender more excellent multifunctional resistance, result ing in a more rapid loss of the fungal pathogen’s fitness. The reason for this relates to the critical scope of Cdc14 regulation – the cell cycle. Mutations in Cdc14 that might confer resistance to the drug should also have detrimental effects on other crucial cellular activities.
60
Made with FlippingBook flipbook maker